Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Total Assets
$10.48M
As of 2025-12-31
$22.81M
As of 2026-06-30
+6.6%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.48M | +318.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.51M | -57.9% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $5.95M | -31.2% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $8.65M | n/m | 2024-09-04, Balance as of period end |
| 2021-12-31 | $651.6K | n/a | 2023-03-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $10.62M | -57.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $10.16M | +146.3% |
| Oragenics Inc (OGEN) | 2025-12-31 | $10.07M | +583.7% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.06M | +78.2% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.04M | -56.8% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $9.94M | +20.8% |
Compare SHPH, TRAW, LGVN, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗